Assignee
EXONHIT THERAPEUTICS SA
FR·12 granted patents·9 pending applications·156 citations·filing 1998–2010
Top patents by PatentIndex Score
21 records- 0178US6552073B1Compounds and methods of treating cell proliferative diseasesEXONHIT THERAPEUTICS SA·Filed 2002·Granted Apr 22, 2003·19 cites·23 claims
- 0276US6372432B1Methods and composition for the detection of pathologic eventsEXONHIT THERAPEUTICS SA·Filed 1999·Granted Apr 16, 2002·46 cites·11 claims
- 0375US8003375B2Qualitative differential screeningEXONHIT THERAPEUTICS SA·Filed 2009·Granted Aug 23, 2011·0 cites·24 claims
- 0472US7790864B2Antibody to BACE455, an alternative splice variant of the human beta-secretaseEXONHIT THERAPEUTICS SA·Filed 2004·Granted Sep 7, 2010·7 cites·1 claims
- 0570US6251590B1Differential Qualitative screeningEXONHIT THERAPEUTICS SA·Filed 1998·Granted Jun 26, 2001·39 cites·25 claims
- 0669US2009264301A1Methods utilizing differential splicing events in blood cells for the detection of pathological eventsEXONHIT THERAPEUTICS SA·Filed 2009·Application pending·0 cites
- 0768US7514432B2Compounds and methods of treating cell proliferative diseases, retinopathies and arthritisEXONHIT THERAPEUTICS SA·Filed 2004·Granted Apr 7, 2009·6 cites·15 claims
- 0868US6881571B1Qualitative differential screeningEXONHIT THERAPEUTICS SA·Filed 1999·Granted Apr 19, 2005·27 cites·22 claims
- 0958US6855736B2Molecular target of neurotoxicityEXONHIT THERAPEUTICS SA·Filed 2001·Granted Feb 15, 2005·3 cites·7 claims
- 1058US2007027146A1Methods of treating nervous disordersEXONHIT THERAPEUTICS SA·Filed 2005·Application pending·0 cites
- 1157US2005043319A1Molecular target of neurotoxicityEXONHIT THERAPEUTICS SA·Filed 2004·Application pending·0 cites
- 1255US7923579B2Tricyclic hydroxamate and benzamide derivatives, compositions and methodsEXONHIT THERAPEUTICS SA·Filed 2004·Granted Apr 12, 2011·1 cites·7 claims
- 1355US2010204251A1Molecular target of neurotoxicityEXONHIT THERAPEUTICS SA·Filed 2009·Application pending·0 cites
- 1453US2009216014A1Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritisEXONHIT THERAPEUTICS SA·Filed 2009·Application pending·0 cites
- 1548US6509153B1Genetic markers of toxicity preparation and usesEXONHIT THERAPEUTICS SA·Filed 1999·Granted Jan 21, 2003·8 cites·25 claims
- 1648US2009269744A1Cancer detection methodEXONHIT THERAPEUTICS SA·Filed 2006·Application pending·0 cites
- 1745US2009317842A1Methods and Tools for The Therapy of Neurodegenerative PathologiesEXONHIT THERAPEUTICS SA·Filed 2007·Application pending·0 cites
- 1844US7872015B2Methods involving PDE4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologiesEXONHIT THERAPEUTICS SA·Filed 2004·Granted Jan 18, 2011·0 cites·3 claims
- 1940US7834163B2Prostate specific genes and the use thereof as targets for prostate cancer therapyEXONHIT THERAPEUTICS SA·Filed 2004·Granted Nov 16, 2010·0 cites·5 claims
- 2040US2010317830A1Bace455, an alternative splice variant of the human beta-secretaseEXONHIT THERAPEUTICS SA·Filed 2010·Application pending·0 cites
- 2137US2008254031A1Tumor Specific Genes and Variant Rnas and Uses Thereof as Targets for Cancer Therapy and DiagnosisEXONHIT THERAPEUTICS SA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EXONHIT THERAPEUTICS SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →